Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome
Publication
, Conference
Lyman, GH; Dale, DC; Wolff, D; Culakova, E; Kuderer, NM; Poniewierski, MS; Crawford, J
Published in: BLOOD
November 16, 2008
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2008
Volume
112
Issue
11
Start / End Page
833 / 833
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
50th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Dale, D. C., Wolff, D., Culakova, E., Kuderer, N. M., Poniewierski, M. S., & Crawford, J. (2008). Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome. In BLOOD (Vol. 112, pp. 833–833). San Francisco, CA: AMER SOC HEMATOLOGY.
Lyman, Gary H., David C. Dale, Debra Wolff, Eva Culakova, Nicole M. Kuderer, Marek S. Poniewierski, and Jeffrey Crawford. “Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome.” In BLOOD, 112:833–833. AMER SOC HEMATOLOGY, 2008.
Lyman GH, Dale DC, Wolff D, Culakova E, Kuderer NM, Poniewierski MS, et al. Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome. In: BLOOD. AMER SOC HEMATOLOGY; 2008. p. 833–833.
Lyman, Gary H., et al. “Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome.” BLOOD, vol. 112, no. 11, AMER SOC HEMATOLOGY, 2008, pp. 833–833.
Lyman GH, Dale DC, Wolff D, Culakova E, Kuderer NM, Poniewierski MS, Crawford J. Standard Versus Dose-Intensified Chemotherapy with Granulocyte Colony-Stimulating Factor for Malignant Lymphoma: Evaluation of Risk for Acute Myeloid Leukemia or Myelodysplastic Syndrome. BLOOD. AMER SOC HEMATOLOGY; 2008. p. 833–833.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2008
Volume
112
Issue
11
Start / End Page
833 / 833
Location
San Francisco, CA
Publisher
AMER SOC HEMATOLOGY
Conference Name
50th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology